Synovial tissue response to treatment with campath‐1h
Open Access
- 1 February 1995
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 38 (2) , 254-258
- https://doi.org/10.1002/art.1780380215
Abstract
Objective. Therapeutic trials in rheumatoid arthritis with the monoclonal antibody Campath‐1H have demonstrated recurrent clinical synovitis in some patients, despite profound depletion of circulating lymphocytes. This study was undertaken to examine the cellular infiltrates in synovial tissue at a time of persistent peripheral lymphopenia. Methods. Immunohistochemical staining of synovial tissue and peripheral blood lymphocyte phenotyping. Results. Synovial tissues from 2 patients with recurrent synovitis after Campath‐1H therapy contained significant T lymphocytic infiltrates at a time when circulating T lymphocytes were markedly depleted. Conclusion. These results demonstrate that peripheral blood analysis may not accurately reflect the synovial tissue response to monoclonal antibody therapy.Keywords
This publication has 9 references indexed in Scilit:
- Effect of Campath-1H antibody on human hematopoietic progenitors in vitroBlood, 1993
- Humanised monoclonal antibody therapy for rheumatoid arthritisThe Lancet, 1992
- How important are t cells in chronic rheumatoid synovitis?Arthritis & Rheumatism, 1990
- The CAMPATH‐1 antigen (CDw52)Tissue Antigens, 1990
- CAMPATH-1M—PROPHYLACTIC USE AFTER KIDNEY TRANSPLANTATIONTransplantation, 1989
- Reshaping human antibodies for therapyNature, 1988
- Increased helper inducer and decreased suppressor inducer phenotypes in the rheumatoid jointArthritis & Rheumatism, 1988
- Total lymphoid irradiation therapy in refractory rheumatoid arthritisArthritis & Rheumatism, 1984
- Lymphocyte Involvement in Rheumatoid ArthritisArthritis & Rheumatism, 1977